Our Integrated Biology (iBio) Graduate Program was fortunate to welcome six new graduate students for the Fall 2026 semester: Cal Baker (iBio PhD, Forbes Lab), Alex Glascock (iBio MS, Neiman Lab), Chelsea Rodriguez (iBio PhD, Forbes Lab), Kushal Raj Roy (iBio PhD, Sung Lab), ...
October 7, 2026 at 2:56 PM
Our Integrated Biology (iBio) Graduate Program was fortunate to welcome six new graduate students for the Fall 2026 semester: Cal Baker (iBio PhD, Forbes Lab), Alex Glascock (iBio MS, Neiman Lab), Chelsea Rodriguez (iBio PhD, Forbes Lab), Kushal Raj Roy (iBio PhD, Sung Lab), ...
Latest company news, September 1: iBio announced its Wells Fargo Healthcare Conference participation. It targets IBIO-600 interim data in Q1 2027.
iBio (#$IBIO): Can Its Obesity Antibodies Deliver Useful Human Data?
www.merlintrader.com/ibio-inc-sto...
iBio (#$IBIO): Can Its Obesity Antibodies Deliver Useful Human Data?
www.merlintrader.com/ibio-inc-sto...
IBio ($IBIO) Stock Hub: Human Data, Cash, Capital Vote
iBio ($IBIO) stock hub: obesity antibodies, Q1 2027 human data, cash runway, pre-funded warrants and the October 14 capital vote, with dated sources.
www.merlintrader.com
October 6, 2026 at 11:18 PM
Latest company news, September 1: iBio announced its Wells Fargo Healthcare Conference participation. It targets IBIO-600 interim data in Q1 2027.
iBio (#$IBIO): Can Its Obesity Antibodies Deliver Useful Human Data?
www.merlintrader.com/ibio-inc-sto...
iBio (#$IBIO): Can Its Obesity Antibodies Deliver Useful Human Data?
www.merlintrader.com/ibio-inc-sto...
... Cecil Smith (iBio PhD, Forbes Lab), and Paulina Sobieralski (iBio MS, Summers Lab).
We wish them all the best as they complete this next phase of their academic journey!
We wish them all the best as they complete this next phase of their academic journey!
October 7, 2026 at 2:56 PM
... Cecil Smith (iBio PhD, Forbes Lab), and Paulina Sobieralski (iBio MS, Summers Lab).
We wish them all the best as they complete this next phase of their academic journey!
We wish them all the best as they complete this next phase of their academic journey!
On Monday, October 12th, our iBio Graduate Student Seminar speakers will be Zhenshen Zhang (Green Lab), Clare Mulcahy (Neiman Lab), and Rebekah Yarvis (Cheng Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend, and we hope to see you there!
October 8, 2026 at 10:16 PM
On Monday, October 12th, our iBio Graduate Student Seminar speakers will be Zhenshen Zhang (Green Lab), Clare Mulcahy (Neiman Lab), and Rebekah Yarvis (Cheng Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend, and we hope to see you there!
Come to TennoVIP, leave with dairy products
Latvietis ibio
Latvietis ibio
October 2, 2026 at 10:51 AM
Come to TennoVIP, leave with dairy products
Latvietis ibio
Latvietis ibio
On Monday, October 5th, our iBio Graduate Student Seminar speakers will be Jessica Miller (HE Lab), Travis Sirevicius (Martin Lab), & Claire Li (Tootle Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend, and we hope to see you there!
October 4, 2026 at 4:09 PM
On Monday, October 5th, our iBio Graduate Student Seminar speakers will be Jessica Miller (HE Lab), Travis Sirevicius (Martin Lab), & Claire Li (Tootle Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend, and we hope to see you there!
Claudio Renio Resines-Dukovny de Ibio
September 26, 2026 at 12:39 PM
Claudio Renio Resines-Dukovny de Ibio
On Monday, September 28th, our iBio Graduate Student Seminar speakers will be Romisa Ghaffari (Comeron Lab), Yiwei Li (Smolikove Lab), and Dakota Thompson (Manak Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend!
September 26, 2026 at 10:00 PM
On Monday, September 28th, our iBio Graduate Student Seminar speakers will be Romisa Ghaffari (Comeron Lab), Yiwei Li (Smolikove Lab), and Dakota Thompson (Manak Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome to attend!
Michelle Gallagher leads Business Development at iBio, University of Limerick, connecting students, academics and employers across the life sciences.
She's speaking at Futura, 19-21 October, Limerick.
futuraevent.com/
She's speaking at Futura, 19-21 October, Limerick.
futuraevent.com/
September 22, 2026 at 11:00 AM
Michelle Gallagher leads Business Development at iBio, University of Limerick, connecting students, academics and employers across the life sciences.
She's speaking at Futura, 19-21 October, Limerick.
futuraevent.com/
She's speaking at Futura, 19-21 October, Limerick.
futuraevent.com/
iBio ($IBIO) Stock Hub 2026: Single-Ascending-Dose Enrollment Completed, First IBIO-600 Interim Data Targeted for Q1 2027
https://merlintrader.com/ibio-inc-stock-hub/
https://merlintrader.com/ibio-inc-stock-hub/
$IBIO IBio: SAD Enrollment Completed, Data In Q1 2027
iBio completed single-ascending-dose enrollment for IBIO-600 and targets the first Phase 1 interim data in the first quarter of 2027.
merlintrader.com
September 18, 2026 at 10:38 AM
iBio ($IBIO) Stock Hub 2026: Single-Ascending-Dose Enrollment Completed, First IBIO-600 Interim Data Targeted for Q1 2027
https://merlintrader.com/ibio-inc-stock-hub/
https://merlintrader.com/ibio-inc-stock-hub/
On Monday, September 21, our iBio Graduate Student Seminar speakers will be Kelsi Mann (Houston Lab) & Varshu Saravanakumar (Neiman Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome, and we hope to see you there supporting our incredible graduate students!
September 19, 2026 at 12:38 PM
On Monday, September 21, our iBio Graduate Student Seminar speakers will be Kelsi Mann (Houston Lab) & Varshu Saravanakumar (Neiman Lab). The first seminar will begin at 3:30 PM in Kollros Auditorium (BBE101). All are welcome, and we hope to see you there supporting our incredible graduate students!
Congratulations to iBio graduate student Daniela Santos Da Mata (Phillips Lab) for receiving a Post-Comprehensive Research Fellowship from the Graduate College for the Fall 2026 semester! 🎉
September 18, 2026 at 12:25 PM
Congratulations to iBio graduate student Daniela Santos Da Mata (Phillips Lab) for receiving a Post-Comprehensive Research Fellowship from the Graduate College for the Fall 2026 semester! 🎉
🚨 $IBIO
iBio, Inc. has updated its corporate presentation.
iBio, Inc. has updated its corporate presentation.
SEC Filing: IBIO
Click to view the official SEC document.
www.sec.gov
September 14, 2026 at 8:17 PM
🚨 $IBIO
iBio, Inc. has updated its corporate presentation.
iBio, Inc. has updated its corporate presentation.
On Monday, September 14th, our iBio Graduate Student Seminar speakers will be MaKella Steffensen (Forbes Lab), Chase Lathrum (Summers Lab), and Eric Anderson (Stipp Lab).
September 13, 2026 at 4:19 PM
On Monday, September 14th, our iBio Graduate Student Seminar speakers will be MaKella Steffensen (Forbes Lab), Chase Lathrum (Summers Lab), and Eric Anderson (Stipp Lab).
www.youtube.com/watch?v=IBio...
Case in point, here this other boss fight where you are teaming up with a bunch of fantasy larpers to fight a jock and his gang on a rollercoaster and they just commit to it instead of having the main character try to act too cool for the nonsence.
Case in point, here this other boss fight where you are teaming up with a bunch of fantasy larpers to fight a jock and his gang on a rollercoaster and they just commit to it instead of having the main character try to act too cool for the nonsence.
Sunset Overdrive PC - King Scab Boss Fight | 4K 60fps Gameplay
YouTube video by 4K no HUD Gameplay
www.youtube.com
September 10, 2026 at 12:59 PM
www.youtube.com/watch?v=IBio...
Case in point, here this other boss fight where you are teaming up with a bunch of fantasy larpers to fight a jock and his gang on a rollercoaster and they just commit to it instead of having the main character try to act too cool for the nonsence.
Case in point, here this other boss fight where you are teaming up with a bunch of fantasy larpers to fight a jock and his gang on a rollercoaster and they just commit to it instead of having the main character try to act too cool for the nonsence.
Era en la zona de la sierra de Ibio me han dicho.
Desde Oyambre se veía perfectamente la columna de humo.
🥺
Desde Oyambre se veía perfectamente la columna de humo.
🥺
September 6, 2026 at 9:42 PM
Era en la zona de la sierra de Ibio me han dicho.
Desde Oyambre se veía perfectamente la columna de humo.
🥺
Desde Oyambre se veía perfectamente la columna de humo.
🥺
iBio ($IBIO) Stock Hub 2026: IBIO-600 Cleared Single-Dose Phase 1, $88 Million In Cash Funds Into 2028
https://www.merlintrader.com/ibio-inc-stock-hub/
https://www.merlintrader.com/ibio-inc-stock-hub/
IBio ($IBIO) Stock Hub 2026: Phase 1 And Share Base
iBio ($IBIO) Stock Hub: IBIO-600 Phase 1, IBIO-610 Activin E data, 2026 catalysts, cash runway and the 154.24M common-plus-pre-funded base.
www.merlintrader.com
September 3, 2026 at 3:45 PM
iBio ($IBIO) Stock Hub 2026: IBIO-600 Cleared Single-Dose Phase 1, $88 Million In Cash Funds Into 2028
https://www.merlintrader.com/ibio-inc-stock-hub/
https://www.merlintrader.com/ibio-inc-stock-hub/
We’re excited to present the Fall 2026 Integrated Biology (iBio) Graduate Students Seminar schedule! Join us on Mondays at 3:30pm in Kollros Auditorium (BBE101) to learn about the exciting and innovative biological research being conducted by our iBio graduate students!
September 2, 2026 at 1:49 PM
We’re excited to present the Fall 2026 Integrated Biology (iBio) Graduate Students Seminar schedule! Join us on Mondays at 3:30pm in Kollros Auditorium (BBE101) to learn about the exciting and innovative biological research being conducted by our iBio graduate students!
"Pharos iBio, Kolon partner to develop lung cancer drug candidate"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
Pharos iBio, Kolon partner to develop lung cancer drug candidate
Pharos iBio, a Korean AI drug-discovery firm, said Wednesday it has signed a joint research and development (R&D) agreement with Kolon Pharma to develop PHI-701, an experimental drug for non-small cell lung cancer (NSCLC), extending an earlier partnership into preclinical and clinical work.The deal
www.koreabiomed.com
September 2, 2026 at 8:00 AM
"Pharos iBio, Kolon partner to develop lung cancer drug candidate"
#medsky #healthcare #hospice #healthpolicy #homehealth
#medsky #healthcare #hospice #healthpolicy #homehealth
#IBIO iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
https://www.stocktitan.net/news/IBIO/i-bio-to-participate-in-the-2026-wells-fargo-annual-healthcare-tq8ign7849t8.html
https://www.stocktitan.net/news/IBIO/i-bio-to-participate-in-the-2026-wells-fargo-annual-healthcare-tq8ign7849t8.html
At Wells Fargo’s healthcare conference, iBio’s CEO will join a live interview
The Sept. 8 session starts at 4:30 p.m. ET in Boston; a livestream and 90-day replay follow, while CFO Felipe Duran joins investor meetings.
www.stocktitan.net
September 1, 2026 at 8:30 PM
#IBIO iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
https://www.stocktitan.net/news/IBIO/i-bio-to-participate-in-the-2026-wells-fargo-annual-healthcare-tq8ign7849t8.html
https://www.stocktitan.net/news/IBIO/i-bio-to-participate-in-the-2026-wells-fargo-annual-healthcare-tq8ign7849t8.html
On Monday, August 31, our iBio Graduate Student Seminar speakers will be Shulin Liu (Fassler Lab) & Daniela Santos Da Mata (Phillips Lab). The seminar will begin at 3:30pm in Kollros Auditorium (BBE101). All are welcome to attend. We hope to see you there supporting our incredible graduate students!
August 29, 2026 at 3:08 PM
On Monday, August 31, our iBio Graduate Student Seminar speakers will be Shulin Liu (Fassler Lab) & Daniela Santos Da Mata (Phillips Lab). The seminar will begin at 3:30pm in Kollros Auditorium (BBE101). All are welcome to attend. We hope to see you there supporting our incredible graduate students!
#IBIO iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
https://www.stocktitan.net/news/IBIO/i-bio-reports-fiscal-year-2026-financial-results-and-provides-yzo30amur4v2.html
https://www.stocktitan.net/news/IBIO/i-bio-reports-fiscal-year-2026-financial-results-and-provides-yzo30amur4v2.html
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
iBio (NASDAQ: IBIO) reported fiscal year 2026 results and a corporate update, highlighted by its transition to a clinical-stage company with the Phase 1 trial of IBIO-600, a long-acting anti-myostatin antibody. The single ascending dose phase dosed 31 of 32 participants across four cohorts with no safety findings that prevented dose escalation, and iBio is preparing multiple ascending dose escalation.The company advanced obesity and cardiometabolic candidates IBIO-610 into IND-enabling studies and IBIO-800 into IND-enabling development, and in-licensed AstralBio’s amylin receptor antibody program. iBio closed an August 2025 public offering with potential gross proceeds up to $100 million and a $26 million private placement in January 2026, and entered a $100 million at-the-market facility. Revenues were $0.1 million versus $0.4 million in 2025; R&D expenses rose to $19.6 million, G&A was $10.6 million, and a $5.0 million intangible impairment was recorded. Net loss was $33.0 million, and cash, cash equivalents and debt securities totaled $88.0 million at June 30, 2026.
www.stocktitan.net
August 28, 2026 at 11:00 AM
#IBIO iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
https://www.stocktitan.net/news/IBIO/i-bio-reports-fiscal-year-2026-financial-results-and-provides-yzo30amur4v2.html
https://www.stocktitan.net/news/IBIO/i-bio-reports-fiscal-year-2026-financial-results-and-provides-yzo30amur4v2.html
🚨 $IBIO
On August 28, 2026, iBio, Inc. issued a press release announcing its financial results for the fiscal year ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the press release attached ...
On August 28, 2026, iBio, Inc. issued a press release announcing its financial results for the fiscal year ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the press release attached ...
SEC Filing: IBIO
Click to view the official SEC document.
www.sec.gov
August 28, 2026 at 12:32 PM
🚨 $IBIO
On August 28, 2026, iBio, Inc. issued a press release announcing its financial results for the fiscal year ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the press release attached ...
On August 28, 2026, iBio, Inc. issued a press release announcing its financial results for the fiscal year ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the press release attached ...